CREATE and WestGene Pair In Vivo CAR Platforms
CREATE Medicines and WestGene entered an R&D and licensing collaboration combining WestGene’s targeted lipid nanoparticle delivery technology with CREATE’s in vivo immune-cell programming platform, aiming to advance dual-targeted and durable in vivo CAR constructs…
